Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of ubiquitination and deubiquitination in PI3K/AKT/mTOR pathway: A potential target for cancer therapy
Jiabei Jin, Jian He, Xinming Li, et al.
Gene (2023) Vol. 889, pp. 147807-147807
Closed Access | Times Cited: 11

Showing 11 citing articles:

Amino acids and KLHL22 do not activate mTORC1 via DEPDC5 degradation
Max L. Valenstein, Pranav V. Lalgudi, Jibril F. Kedir, et al.
Nature (2025) Vol. 637, Iss. 8045, pp. E11-E14
Closed Access | Times Cited: 1
Targeting the Ubiquitin–Proteasome System and Recent Advances in Cancer Therapy
Daniela Spano, Giuliana Catara
Cells (2023) Vol. 13, Iss. 1, pp. 29-29
Open Access | Times Cited: 17
Protein Stability Regulation in Osteosarcoma: The Ubiquitin-like Modifications and Glycosylation as Mediators of Tumor Growth and as Targets for Therapy
Jacopo Di Gregorio, Laura Di Giuseppe, Sara Terreri, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 537-537
Open Access | Times Cited: 3
Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways
Fang Tian, Shiheng Hu, Xinhao Song, et al.
Breast Cancer Research and Treatment (2024) Vol. 207, Iss. 2, pp. 435-451
Closed Access | Times Cited: 3
Emerging treatment approaches for triple-negative breast cancer
Maurizio Capuozzo, Venere Celotto, Mariachiara Santorsola, et al.
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 8
CALU promotes lung adenocarcinoma progression by enhancing cell proliferation, migration and invasion
Yan Li, Shengnan Sun, Hui Zhang, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Saba Asadi, et al.
Non-coding RNA Research (2024) Vol. 10, pp. 1-15
Open Access | Times Cited: 1
Roles of deubiquitinases in urologic cancers (Review)
Liang-Pei Wu, Jiahui Wang, Linjiang Chai, et al.
Oncology Letters (2024) Vol. 28, Iss. 6
Open Access
In Vitro Characterization of Inhibition Function of Calcifediol to the Protease Activity of SARS‐COV‐2 PLpro
Junjie Chen, Yaya Zhang, Bingchang Zhang, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 11
Closed Access
Non-coding RNAs and regulation of the PI3K signaling pathway in lung cancer: recent insights and potential clinical applications
Mehrdad Hashemi, Asal Abolghasemi Fard, Bita Pakshad, et al.
Non-coding RNA Research (2024) Vol. 11, pp. 1-21
Open Access
Advancements in Clinical Research and Emerging Therapies for Triple-Negative Breast Cancer Treatment
Lili Xu, Pengtao Xu, Jingsong Wang, et al.
European Journal of Pharmacology (2024), pp. 177202-177202
Closed Access
Page 1

Scroll to top